Actinium Pharmaceuticals, Inc. (ATNM) Revenue 2021–2025
Actinium Pharmaceuticals, Inc. (ATNM) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$90,000FY2025 · since FY2021: $1.1M → $90,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $90,000 | — |
| FY2023 | $81,000 | -92.1% |
| FY2022 | $1.0M | -10.0% |
| FY2021 | $1.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ATNM financial trends
ATNM Net incomeATNM Net marginATNM Gross profitATNM Gross marginATNM Operating incomeATNM Operating marginATNM Operating cash flowATNM Free cash flowATNM Capital expendituresATNM Return on equityATNM Stock buybacksATNM Dividends paidATNM Total assetsATNM Total liabilitiesATNM Shareholders’ equityATNM overview →